The Side Effects of Testosterone Replacement Therapy w/ Peter Attia

Peter Attia on TRT Side Effects: A Clinician's Honest Assessment

Peter Attia does not sugarcoat things, and that directness is exactly what the TRT side effects conversation needs. Too many discussions of TRT either minimize the side effects to sell you on treatment or exaggerate them to scare you away from it. Attia, speaking in conversation with Jillian Michaels, lays out the side effect profile of testosterone replacement therapy with the kind of clinical honesty that helps people make real decisions based on real information.

What makes this discussion particularly useful is that Attia speaks from the perspective of a physician who prescribes and manages TRT daily. He is not theorizing about what might happen. He is describing what he actually sees in his patient population and how he manages it. That practical experience grounds the conversation in reality rather than hypothetical risk assessment.

The Side Effects Worth Taking Seriously

Attia organizes TRT side effects into categories based on their clinical significance, which is a more useful framework than treating all side effects as equally concerning. At the top of his list is polycythemia, the elevation of red blood cell count that can increase blood viscosity and clotting risk. He describes this as the most common side effect that requires active management and the one he monitors most closely in his patients.

His approach to polycythemia management is primarily through protocol optimization. He prefers to adjust injection frequency and dose before resorting to phlebotomy, noting that more frequent, smaller doses tend to produce less erythropoietic stimulation than less frequent, larger doses. When phlebotomy is needed, he uses it as a bridge while making protocol changes rather than as a long-term management strategy.

Fertility suppression gets significant attention in this conversation. Attia is clear that exogenous testosterone will suppress sperm production in essentially all men, and he notes that this effect can take 6 to 12 months to fully reverse after stopping TRT (and in some cases, recovery is incomplete). For any man who might want children in the future, this is a conversation that needs to happen before the first injection, not after.

Estrogen-Related Side Effects

The discussion of estrogen management reflects the evolving standard of care in TRT. Attia describes his current approach as starting without an aromatase inhibitor and only adding one if estradiol becomes problematically elevated on bloodwork. He notes that many of the symptoms attributed to high estrogen (water retention, moodiness, soft erections) can also be caused by testosterone levels that are too high, injection frequency that is too low, or factors entirely unrelated to hormones.

Gynecomastia (breast tissue development) is discussed as a side effect that, while not dangerous, causes significant distress in men who develop it. Attia notes that early-stage gynecomastia (tenderness and swelling without hard tissue formation) is often reversible with estrogen management. Once hard, fibrous tissue has formed, it typically requires surgical removal. Catching it early through patient awareness and regular physical assessment is the key to prevention.

The point about estradiol having genuine health benefits is one Attia returns to repeatedly. Crashing estradiol with aggressive AI use is, in his view, worse than having mildly elevated estradiol in most cases. Joint pain, bone density loss, cognitive impairment, and worsened lipid profiles are all consequences of estradiol suppression that outweigh the modest benefit of avoiding water retention or mild mood fluctuations.

Skin and Hair Effects

Acne and oily skin are among the most common quality-of-life side effects of TRT. Attia notes that these tend to be worst in the first 3 to 6 months of treatment and often improve as the body adjusts. His first-line approach is protocol optimization (reducing peaks through more frequent dosing), followed by basic skincare interventions, with dermatological referral for persistent cases.

Hair loss is addressed with appropriate nuance. Attia acknowledges that TRT can accelerate androgenetic alopecia in genetically predisposed men through increased DHT production. He discusses finasteride as an option but notes the trade-offs, including potential sexual side effects and the reduction of DHT, which has its own biological functions. His preference is to give patients the full picture and let them make an informed choice about whether hair preservation justifies the risks of adding another medication.

Skin changes beyond acne include increased body hair growth and changes in body odor. These are generally mild and rarely cause enough concern to warrant treatment modification, but they are worth mentioning because they surprise some patients who were not expecting them.

Cardiovascular Considerations in Practice

Attia's take on cardiovascular risk from TRT is informed by the TRAVERSE trial data and his clinical experience. He positions cardiovascular risk from TRT as low in properly selected and monitored patients, and he notes that the metabolic benefits of treating hypogonadism (improved insulin sensitivity, reduced visceral fat, better exercise capacity) may actually provide net cardiovascular benefit for many men.

His monitoring protocol includes regular blood pressure checks, lipid panels, hematocrit monitoring, and attention to symptoms that could suggest cardiovascular issues. He is pragmatic about the fact that most men on TRT are middle-aged or older and already carry some cardiovascular risk factors, making thorough cardiac monitoring standard practice regardless of TRT status.

Sleep apnea screening is part of his baseline workup for TRT patients. He notes that testosterone can worsen existing sleep apnea and that untreated sleep apnea independently worsens cardiovascular risk, metabolic health, and quality of life. Treating sleep apnea is therefore both a safety measure for TRT and a health intervention in its own right.

The Risk-Benefit Framework

Perhaps the most valuable takeaway from this conversation is Attia's approach to thinking about side effects in context. He does not dismiss any side effect as trivial, but he also does not present the side effect profile as a reason to avoid TRT when it is clinically indicated. His framework is straightforward: every medication has side effects, and the question is whether the benefits of treatment justify the risks for a specific patient when those risks are managed competently.

For a man with symptomatic hypogonadism, fatigue, depression, metabolic dysfunction, and progressive muscle and bone loss, the side effects of TRT managed by a competent provider are, in Attia's assessment, almost always outweighed by the benefits. The key qualifier is "managed by a competent provider." Unsupervised or poorly monitored TRT is a different risk proposition entirely.

Who Should Watch This

This video is ideal for men who are weighing the decision to start TRT and want a thorough, physician-level discussion of what to expect. It is also valuable for men already on TRT who want to benchmark their provider's monitoring approach against what a top-tier longevity physician considers standard of care. If you are experiencing side effects and wondering whether they are normal, manageable, or a sign that something needs to change, this conversation provides the context to have that discussion with your own provider.

Building Your Personal Side Effect Management Plan

The most proactive approach to TRT side effects is to build a management plan before you start treatment rather than reacting to problems as they arise. This plan should include baseline bloodwork (CBC, metabolic panel, lipids, PSA, estradiol, total and free testosterone, thyroid function), a screening for sleep apnea if you have risk factors, and a clear understanding of which symptoms to monitor and report.

Once on treatment, maintaining a simple weekly log of key symptoms (energy, mood, sleep quality, libido, any new symptoms) creates a record that is invaluable during follow-up appointments. Patterns that are obvious in a log, like mood dips on days 5 and 6 of your injection cycle, can be invisible when you are trying to remember how you felt over the past month during a 15-minute appointment.

This conversation between Attia and Jillian Michaels provides the foundation for thinking about side effects as manageable realities rather than deal-breaking fears. Every medication comes with trade-offs. The men who succeed on TRT long-term are the ones who understand those trade-offs, monitor proactively, communicate openly with their providers, and approach the process with the patience required to optimize a protocol that will serve them for years or decades. Attia's practical, data-driven approach to side effect management is a model worth emulating regardless of who your provider happens to be.

If you are considering TRT and side effect concerns are holding you back, this video deserves your attention. The honest, detailed discussion of what to actually expect, how to monitor, and how to manage is exactly the kind of information that turns anxiety into actionable knowledge. And actionable knowledge is the best foundation for any medical decision.

The quality of the conversation between Attia and Michaels also demonstrates the value of patient education. An informed patient who understands the side effect profile of their medication is better equipped to monitor for problems, report symptoms accurately, and participate meaningfully in treatment decisions. This video contributes to that education in a way that is thorough without being alarmist, and that balance is difficult to achieve but essential for empowering patients to manage their health effectively.

Whether you are about to start TRT, currently on it, or simply researching it for the future, the side effect framework Attia presents here will serve you well. Understand the risks, monitor for them systematically, work with a competent provider, and maintain the perspective that managed risks are an acceptable price for genuine improvements in health and quality of life. That is the heart of responsible testosterone therapy, and this video delivers that message with clarity and credibility.